title: Inadequate numbers.
authors.forename: Karen L
authors.initials: KL
authors.lastname: Lindsay
authors.forename: Michael F
authors.initials: MF
authors.lastname: Greene
authors.forename: Judith K
authors.initials: JK
authors.lastname: Jones
authors.forename: Willis C
authors.initials: WC
authors.lastname: Maddrey
authors.forename: Richard K
authors.initials: RK
authors.lastname: Miller
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D018812:Paternal Exposure; D011247:Pregnancy; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage* / Q000009:adverse effects; D018570:Risk Assessment; D013723:Teratogens
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013723:Teratogens; D012254:Ribavirin